A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease.

C Anasetti; P J Martin; J A Hansen; F R Appelbaum; P G Beatty; K Doney; S Harkonen; A Jackson; T Reichert; P Stewart

doi:10.1097/00007890-199007000-00010

A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease.

Identifier:nobleid.org/w1/20260515/8EAF84DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/8EAF84DF.svg?ark=w1%2F20260515%2F8EAF84DF)](https://nobleid.org/work/w1/20260515/8EAF84DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease.

Identifier:nobleid.org/w1/20260515/8EAF84DF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/8EAF84DF.svg?ark=w1%2F20260515%2F8EAF84DF)](https://nobleid.org/work/w1/20260515/8EAF84DF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work